# US 2021/0275570 A1 · Use of mannuronic diacid composition in treatment of inflammation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275570 A1
- Document ID: US20210275570A1
- Status: Published application
- Kind: A1
- Application number: 17/256,854
- Filed: 2019-06-28
- Published: 2021-09-09
- Earliest claimed: 2018-06-29
- Assignees: Shanghai Green Valley Pharmaceutical Co., Ltd.; Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Applicants: Shanghai Green Valley Pharmaceutical Co., Ltd.; Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Inventors: Meiyu Geng; Xianliang Xin; Zhenqing Zhang; Jian Ding
- Web page: https://patentgrep.com/patent/US20210275570A1

## CPC

- A61K 31/734: Alginic acid
- A61K 31/7012: Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid (gluconic acid A61K31/191; ascorbic acid A61K31/375)
- A61K 31/7016: Disaccharides, e.g. lactose, lactulose (lactobionic acid A61K31/7032)
- A61K 31/702: Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 37/02: Immunomodulators
- A61P 37/06: Immunosuppressants, e.g. drugs for graft rejection
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to the use of mannuronic diacid oligosaccharide composition in the treatment of inflammation.

## Claims

### Claim 1

A method of treating a patient suffering from inflammation or pain produced from inflammation; comprising administering to the patient an effective amount of the mannuronic diacid oligosaccharide composition, wherein the mannuronic diacid oligosaccharide composition comprises a mannuronic diacid of Formula (III) or a pharmaceutically acceptable salt thereof:
wherein n is an integer selected from 1 to 9, m is selected from 0, 1 or 2, m′ is selected from 0 or 1, and
wherein,
the total weight of mannuronic diacids wherein n=1-5 accounts for no less than 60% of the total weight of the composition;
the total weight of mannuronic diacids wherein n=1-2 accounts for less than 60% of the total weight of the composition.

### Claim 2 (depends on 1)

The method of claim 1, wherein the inflammation is vascular inflammation, neuroinflammation, arthritis, ankylosing spondylitis, inflammatory bowel disease, inflammatory diabetic ulcer, inflammatory skin disease or systemic lupus erythematosus.

### Claim 3 (depends on 1)

The method of claim 1, wherein in the mannuronic diacid oligosaccharide composition, the total weight of mannuronic diacids wherein n=1-2 accounts for 10-50% of the total weight of the composition.

### Claim 4 (depends on 1)

The method of claim 1, wherein in the mannuronic diacid oligosaccharide composition, the ratio of the total weight of mannuronic diacids wherein n=1-3 to the total weight of mannuronic diacids wherein n=4-7 is between 1.0 and 3.5.

### Claim 5 (depends on 1)

The method of claim 1, wherein in the mannuronic diacid oligosaccharide composition, the total weight of mannuronic diacids with m+m′=1 or 2 is no less than 50% of the total weight of the composition.

### Claim 6 (depends on 5)

The method of claim 5, wherein the total weight of mannuronic diacids with m+m′=1 is no less than 10% of the total weight of the composition.

### Claim 7 (depends on 5)

The method of claim 5, wherein the total weight of mannuronic diacids with m+m′=2 is no less than 10% of the total weight of the composition.

### Claim 8 (depends on 1)

The method of claim 1, wherein the total weight of mannuronic diacids wherein n=1-5 accounts for 80-95% of the total weight of the composition.

### Claim 9 (depends on 1)

The method of claim 1, wherein the total weight of mannuronic diacids wherein n=1-3 accounts for 20-70% of the total weight of the composition.

### Claim 10 (depends on 4)

The method of claim 4, wherein the ratio of the total weight of mannuronic diacids wherein n=1-3 to the total weight of mannuronic diacids wherein n=4-7 is between 1.0 and 3.0.

### Claim 11 (depends on 1)

The method of claim 1, wherein the weight percentage content of mannuronic diacids with each of polymerization degrees in the composition is: disaccharide 5-25%, trisaccharide 15-30%, tetrasaccharide 15-28%, pentasaccharide 5-25%, hexasaccharide 2-20%, heptsaccharide 2-20%, octasaccharide 2-20%, nonasaccharide 2-20%, decasaccharide 2-20%.

### Claim 12 (depends on 11)

The method of claim 11, wherein the weight percentage content of mannuronic diacids with each of polymerization degrees in the composition is: disaccharide 5-25%, trisaccharide 15-30%, tetrasaccharide 15-28%, pentasaccharide 10-20%, hexasaccharide 5-15%, heptsaccharide 3-10%, octasaccharide 2-5%, nonasaccharide 1-5%, decasaccharide 1-5%.

### Claim 13 (depends on 12)

The method of claim 12, wherein the weight percentage content of mannuronic diacids with each of polymerization degrees in the composition is: disaccharide 10-20%, trisaccharide 18-30%, tetrasaccharide 15-28%, pentasaccharide 15-20%, hexasaccharide 5-10%, heptsaccharide 3-5%, octasaccharide 2-5%, nonaccharide 1-3%, decasaccharide 1-3%.

### Claim 14 (depends on 1)

The method of claim 1, wherein the pharmaceutically acceptable salt is sodium salt or potassium salt.

### Claim 15

(canceled)

### Claim 16 (depends on 1)

The method of claim 1, wherein in the mannuronic diacid oligosaccharide composition, the total weight of mannuronic diacids wherein n=1-2 accounts for 30-50% of the total weight of the composition.

### Claim 17 (depends on 1)

The method of claim 1, wherein in the mannuronic diacid oligosaccharide composition, the total weight of mannuronic diacids with m+m′=1 or 2 is 60%-90% of the total weight of the composition.

### Claim 18 (depends on 17)

The method of claim 17, wherein the total weight of mannuronic diacids with m+m′=1 is 30-40% of the total weight of the composition.

### Claim 19 (depends on 17)

The method of claim 17, wherein the total weight of mannuronic diacids with m+m′=2 is 30-50% of the total weight of the composition.

### Claim 20 (depends on 13)

The method of claim 13, wherein the pharmaceutically acceptable salt is sodium salt or potassium salt.
